Курзанов А. Н., Ледванов М. Ю., Быков И. М., Медведев В. Л., Стрыгина Е. А., Бизенкова М. Н., Заболотских Н. В., Ковалев Д. В., Стукова Н. Ю.,
Список литературы к главе 4
1. Abdallah Y., Ross G., Dolf A. et al. N-terminal parathyroid hormone-related peptide hyperpolarizes endothelial cells and causes a reduction of the coronary resistance of the rat heart via endothelial hyperpolarization Peptides. 2006; 27 (11): 2927-2934.
2. Angerаs O., Albertsson P., Karason K. et al. Evidence for obesity paradox in patients with acute coronary syndromes: a report from the Swedish Coronary Angiography and Angioplasty Registry. Eur Heart J. 2013; 34: 345-353.
3. Aukland K., Reed R.K. (1993) Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73: 1–78.
5. Bui T.D., Shallal A., Malik A.N. et al. Parathyroid hormone related peptide gene expression in human fetal and adult heart Cardiovasc Res. 1993; 27: 1204-1208.
6. Burtis W.J., Wu T., Bunch C. et al. Identification of a novel 17,000-dalton parathyroid hor-mone-like adenylatecyclase-stimulating protein from a tumor associated with humoral hyper-calcemia of malignancy. J. Biol. Chem. 1987; 262: 7151–7156.
7. Burton D.W., Brandt D.W., Deftos L.J. Parathyroid hormone-related protein in the cardiovascular system Endocrinology. 1994; 135: 253- 261.
8. Camici M., Galetta F., Franzoni F., Carpi A. Obesity paradox. Integr Obesity Diabetes. 2015; Volume 1 (3): 61-65.
9. Chukkapalli S., Zhan E., Lasley R., Datta N.S. Abstract 15371: Parathyroid Hormone-Related Peptide Protects Cardiomyocytes from Oxidative Stress: First Evidence of a Novel Endocrine-Cardiovascular Interaction. Circulation. 2014; 130: A15371.
10. Clemens T.L., Cormier S., Eichinger A. et al. Parathyroid hormone-related protein and its receptors: nuclear functions and roles in the renal and cardiovascular systems, the placental trophoblasts and the pancreatic islets. Br. J. Pharmacol. 2001; Nov; 134 (6): 1113–36.
11. Collip J.B., Clark E.P. Further studies on the physiological action for parathyroid hormone. J. Biol. Chem. 1925; 64: 485–507.
12. Curtis J.P., Selter J.G., Wang Y. The obesity paradox: body mass index and outcomes in patients with heart failure. ArhInt. Med. 2005; 165: 55-61.
13. Daifotis A.G., Weir E.C., Dreyer B.E., Broadus A.E. Stretch-induced parathyroid hormone-related peptide gene expression in the rat uterus. J. Biol. Chem. 1992; 267: 23455–23458.
14. Datta N.S., Chukkapalli S., Vengalil N. et al. Parathyroid hormone-related peptide protects cardiomyocytes from oxidative stress-induced cell death: First evidence of a novel endocrine-cardiovascular interaction. BiochemBiophys Res Commun. 2015; 468 (1–2): 202–207.
15. Datta T., Przyklenk K., Datta N.S. Parathyroid Hormone–Related Peptide: A Novel Endocrine Cardioprotective “Conditioning Mimetic”. Journal of Cardiovascular Pharmacology and Therapeutics. 2017.10.1177/1074248417702976.
16. Deftos L.J., Burton D.W., Brandt D.W. Parathyroid hormone-like protein is a secretory product of atrial myocytes. J. Clin. Invest. 1993; 92: 727-735.
17. Ferguson J.E., Seaner R.M., Bruns D.E. et al. Expression and specific immunolocalization of the human parathyroid hormone/parathyroid hormone-related protein receptor in the uteroplacental unit. Am. J. Obstet. Gynecol. 1998; 179: 321–329.
18. Fiaschi-Taesch N.M., Stewart A.F. Minireview: parathyroid hormone-related protein as an in-tracrine factor-trafficking mechanisms and functional consequences. Endocrinology. 2003; 144 (2): 407–411.
19. Fineman J.R., Soifer S.J., Heymann M.A. Regulation of pulmonary vascular tone in the perinatal period. Annu Rev Physiol. 1995; 57: 115–134.
20. Flugelman M.E., Virmani R., Correa R., Yu Z.X., Farb A., Leon M.B., Elami A., Fu Y.M., Casscells W., Ebstein S.E. Smooth muscle cell abundance and fibroblast growth factors in coronary lesions of patients with nonfatal unstable angina: a clue to the mechanism of transformation from the stable to the unstable clinical state. Circulation. 1993; 88: 2493-2500.
21. Fonarow G.C., Srikanthan P., Costanzo M.R. et al. ADHERE Scientific Advisory Committee and Investigators An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am. Heart J. 2007; 153: 74-81.
22. Fritsch S., Lindner V., Welsch S. et al. Intravenous delivery of PTH/PTHrP type 1 receptor cDNA to rats decreases heart rate, blood pressure, renal tone, renin angiotensin system, and stress-induced cardiovascular responses. J. Am. SocNephrol. 2004; 15 (10): 2588–600.
23. Funk J.L, Migliati E., Chen G., Wei H., Wilson J., Downey K.J., Mullarky P.J., Coull B.M., McDonagh P.F., Ritter L.S. Parathyroid hormonerelated protein induction in focal stroke: a neuroprotective vascular peptide. Am J Physiol Regul Integr Comp Physiol. 2003; 284: R1021–R1030.
24. Funk J.L., A role for parathyroid hormone-related protein in the pathogenesis of inflammatory/autoimmune diseases. Int Immunopharmacol. 2001; 1: 1101–1121.
25. Funk J.L., Cordaro L.A., Wei H., Benjamin J.B., Yocum D.E. Synovium as a source of increased amino-terminal parathyroid hormone-related protein expression in rheumatoid arthritis. J Clin Invest. 1998; 101: 1362–1371.
26. Funk J.L., Trout C.R., Wei H., Stafford G., Reichlin S. Parathyroid hormone-related protein (PTHrP) induction in reactive astrocytes following brain injury: a possible mediator of CNS inflammation. Brain Res.2001; 12; 915: 195–209.
27. Gao Y., Raj J.U. Role of veins in regulation of the pulmonary circulation. Am J Physiol Lung Cell Mol Physiol. 2005; 288: 213–226.
28. Gensure R.C., Gardella T.J., Juppner H.: Parathyroid hormone and parathyroid hormonerelated peptide, and their receptors. BiochemBiophys Res Commun. 2005; 328 (3): 666-678.
29. Gordon J., Strewler M.D. The physiology of parathyroid hormone-related protein. NEngl. J. Med. 2000; 342: 177–185.
30. Grohe C., Schluter K-D. Parathyroid hormone-related protein (PTHrP) signal cascade modulates myocardial dysfunction in the pressure overloaded heart. European Journal of Heart Failure. 2007; 9: 1156–1162.
31. Grohe C., van Eickels M., Wenzel S. et al. Sex-specific differences in ventricular expression and function of parathyroid hormone-related peptide. Cardiovasc. Res. 2004; Feb 1; 61 (2): 307–16.
32. Halapas A., Tenta R., Pantos C. et al. Parathyroid hormone-related peptide and cardiovascular system. In Vivo. 2003; Sep-Oct; 17 (5): 425-32.
33. Holt E.H., Lu C., Dreyer B.E. et al. Regulation of parathyroid hormone-related peptide gene expression by estrogen in GH4C1 rat pituitary cells has the pattern of a primary response gene. J Neurochem. 1994; 62: 1239–1246.
34. Hongo T., Kupfer J., Enomoto H. et al. Abundant expression of parathyroid hormone-related protein in primary rat aortic smooth muscle cells accompanies serum-induced proliferation. J. Clin. Invest. 1991; 88: 1841–1847.
35. Ishikawa M., Akishita M., Kozaki K., Toba K., Namiki A., Yamaguchi T., Orimo H., Ouchi Y. Expression of parathyroid hormone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening. Atherosclerosis. 2000; 152: 97–105.
36. Ishikawa M., Akishita M., Kozaki K., Toba K., Namiki A., Yamaguchi T., Orimo H., Ouchi Y. Expression of parathyroid hormone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening. Atherosclerosis. 2000; 152: 97–105.
37. Ishikawa M., Akishita M., Kozaki K. et al. Amino-terminal fragment (1–34) of parathyroid hormone-related protein inhibits migration and proliferation of cultured vascular smooth muscle cells. Atherosclerosis. 1998; 136: 59–66.
38. Ishikawa M., Ouchi Y., Akishita M. et al. Immunocytochemical detection of parathyroid hormone-related protein in vascular endothelial cells. Biochem. Biophys. Res. Commun. 1994a; 199: 5447–5451.
39. Ishikawa M., Ouchi Y., Han S. et al. Parathyroid hormone-related protein reduces cytosolic free Ca2+ level and tension in rat aortic smooth muscle. Eur. J. Pharmacol. 1994b; 269: 311–317.
40. Jans D.A., Thomas R.J., Gillespie M.T. Parathyroid hormone-related protein (PTHrP): a nu-cleocytoplasmic shuttling protein with distinct paracrine and intracrine roles. Vit-am. Horm. Vitamins&Hormones. 2003; 66: 345–384.
41. Jansen J, Gres P., Umschlag C. et al. Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. Am. J. Physiol. 2003; 284: H49–H55.
42. Jiang B., Morimoto S., Fukuo K. et al. Role of parathyroid hormone-related protein in the proliferation of vascular smooth muscle cells. Miner. Electrolyte Metab. 1995; 21: 157–160.
43. Jiang B., Morimoto S., Yang J. et al. Expression of parathyroid hormone/parathyroid hormone-related protein receptor in vascular endothelial cells. J. Cardiovasc. Pharmacol. 1998; 31: S142–S144.
44. Kalantar-Zadeh K., Streja E., Kovesdy C.P. et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin. Proc. 2010; 85: 991–1001.
45. Kalinowski L., Dobrucki L.W., Malinski T. Nitric oxide as a second messenger in parathyroid hormone-related protein signaling. J. Endocrinol. 2001; 170: 433–440.
46. Kiriyama T., Fujiyama K., Nagao S., Shinji Seto, Naokata Yokoyama, Shigenobu Nagataki. Parathyroid hormone-related protein (PTHrP) and blood pressure. Journal of Bone and Mineral Metabolism.1994; 12 (1): 183–186.
47. Kline L.W., Benishin C.G., Pang P.K. Parathyroid hormone (PTH) and parathyroid hormone-related protein (PTHrP) relax cholecystokinin-induced tension in guinea pig gallbladder strips. Regul Pept. 2000; 91 (1–3): 83–88.
48. Lanske B., Divieti P., Kovacs C.S. et al. The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands inmurine bone. Endocrinology. 1998; 139: 5194–5204.
49. Lanske B., Karaplis A., Lee K. et al. PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science. 1996; 273: 663–666.
50. Lerner D.J., Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year followup of the Framingham population. Am. Heart J. 1986. 11: 383–390.
51. Luparello C. MidregionPTHrP and human breast cancer cells. Sci. World J. 2010; 10: 1016–1028.
52. Lutteke D., Ross G., Abdallah Y. et al. Parathyroid hormone–related peptide improves contractile responsiveness of adult rat cardiomyocytes with depressed cell function irrespectively of oxidative inhibition. Basic Res. Cardiol. 2005; 100: 320-327.
53. Macgill K., Moseley J.M., Martin T.J. et al. Vascular effects of PTHrP (1–34) and PTH (1–34) in the human fetal-placental circulation. Placenta. 1997; 18: 587–592.
54. Maeda S., Sutliff R.L., Qian J. et al. Targeted overexpression of parathyroid hormone-related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility. Endocrinology. 1999; 140: 1815-1825.
55. Mandsager N.T., Brewer A.S., Myatt L. Vasodilator effects of parathyroid hormone, parathyroid hormone-related protein, and calcitonin gene-related peptide in the human fetal-placental circulation. J. Soc. Gynecol. Investig. 1994; 1: 19–24.
56. Martin T.J., Moseley J.M., Williams E.D. Parathyroid hormone–related protein: hormone and cytokine. J Endocrinol. 1997; 154: 23–37.
57. Martin-Ventura J., Ortego M., Esbrit P., Hernandez-Presa M., Ortega L., Egido J. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke. 2003; 34: 1783–1789.
58. Massfelder T., Fiaschi-Taesch N., Stewart A.F., Helwig J.J. Parathyroid hormonerelated peptide–a smooth muscle tone and proliferation regulatory protein. CurrOpinNephrolHypertens. 1998; 7: 27–32.
59. Massfelder T., Hewlig J.-J., Stewar A.F. Editorial: parathyroid hormone-related protein as a cardiovascular regulatory peptide. Endocrinology. 1996b; Vol. 137, 8: 3151–3153.
60. Massfelder T., Stewart A.F., Endlich K. et al. Parathyroid hormone-related protein detection and interaction with NO and cyclic AMP in the renovascular system. Kidney Int. 1996a; 50: 1591–1603.
61. Massfelder T., Taesch N., Endlich N. et al. Paradoxical actions of exogenous and endogenous parathyroid hormone-related protein on renal vascular smooth muscle cell proliferation: reversion in the SHR model of genetic hypertension. FASEB J. 2001; 15: 707–718.
62. Massfelder T., Helwig J.J. Parathyroid hormone-related protein in cardiovascular development and blood pressure regulation. Endocrinology. 1999; 140: 1507–1510.
63. Meyer R., Schreckenberg R., Kraus D.F. et al. Cardiac Effects Of Osteostatin In Mice. Journal Of Physiology And Pharmacology. 2012; 63, 1: 17-22
64. Meyer R., Schreckenberg R., Kretschmer F. et al. Parathyroid hormone-relatedprotein (PTHrP) signal cascade modulates myocardial dysfunction in the pressure overloaded heart. European Journal of Heart Failure. 2007; 9: 1156–1162.
65. Meziani F., Van Overloop B., Schneider F., Gairard A. Parathyroid hormone-related protein-induced relaxation of rat uterine arteries: influence of the endothelium during gestation. J Soc Gynecol Investig. 2005; 12: 14–19.
66. Meziani F., Tesse A., Welsch S., Hele ne Kremer, Mariette Barthelmebs, Ramaroson Andriantsitohaina, Francis Schneider, Alexis Gairard; Expression and Biological Activity of Parathyroid Hormone-Related Peptide in Pregnant Rat Uterine Artery: Any Role for 8-IsoProstaglandin F2, Endocrinology. 2008; 149 (2): 626–633.
67. Mirfakhraee S. and Towler D.A. – Cardiovascular actions of parathyroid hormone/parathyroid hormone–related protein signaling. In “Principles of Bone Biology” (4th Edition). 2019. Editors: John Bilezikian T. John Martin Thomas Clemens Clifford Rosen. Chapter 26. Pages 623-644.
68. Mizuno R., Ono N., Ohhashi T. Parathyroid hormone-related protein-(1–34) inhibits intrinsic pump activity of isolated murine lymph vessels. American Journal of Physiology – Heart and Circulatory Physiology Published 1 July 2001; 281 (1): H60-H66.
69. Mizuno R., Koller A., Kaley G. Regulation of the vasomotor activity of lymph microvessels by nitric oxide and prostanoids. Am J Physiol Regulatory Integrative Comp Physiol. 1998; 274: R790–R796.
70. Mok L.L., Nickols G.A., Thompson J.C., Cooper C.W. Parathyroid Hormone As A Smooth Muscle relaxant. Endocrine Rev. 1989; 10: 420–436.
71. Monego G., Arena V., Pasquini S. et al. Ischemic injury activates PTHrP and PTH1R expression in human ventricular cardiomyocytes. Basic Res Cardiol. 2009; 104 (4): 427–434.
72. Moniz C. Parathyroid hormone related peptide gene expression in human fetal and adult heart. Cardiovasc Res. 1993; 27: 1204-1208.
73. Moseley J.M., Kubota M., Diefenbach-Jagger H. et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. PNAS. 1987; 84: 5048–5052.
74. Musso M.J., Plante M., Judes C. et al. Renal vasodilatation and microvessel adenylate cyclase stimulation by synthetic parathyroid hormone-like protein fragments. Eur. J. Pharmacol. 1989; 174: 139–151.
75. Nabuyoshi M., Sekine M., Yamashita S. Coronary atherosclerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. BiochemBiophys Res Commun. 1994; 200: 1028-1035.
76. Nagao S., Seto S., Kitamura S. et al. Central pressor effect of parathyroid hormonerelated protein in conscious rats. Brain Res. 1998; 785: 75-79.
77. Nakayama T., Ohtsuru A., Enomoto H. et al. Coronary atheroslcerotic smooth muscle cells overexpress human parathyroid hormone-related peptides. Biochem. Biophys. Res. Commun. 1994; 200: 1028–1035.
78. Nickols G.A., Nana A.D., Nickols M.A. et al. Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor. Endocrinology. 1989; 125: 834–841.
79. Nickols G.A., Nickols M.A., Helwig J.J. Binding of parathyroid hormone and parathyroid hormone-related protein to vascular smooth muscle of rabbit renal microvessels. Endocrinology. 1990; 126: 721–727.
80. Nagasaki K., Yamaguchi K., Miyake Y. et al. In vitro and in vivo antagonists against parathyroid hormone-related protein. Biochem Biophys Res Commun. 1989; 158: 1036–1042.
81. Noda M., Katoh T., Kurokawa K., Takuwa Y. Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats. Hypertension. 1997; 30: 1284–1288.
82. Noda M., Katoh T., Takuwa N. et al. Synergistic stimulation of parathyroid hormone-related peptide gene expression by mechanical stretch and angiotensin II in rat aortic smooth muscle cells. J. Biol. Chem. 1994; 269: 17911–17917.
83. Ohhashi T., Azuma T., Sakaguchi M. Active and passive mechanical characteristics of bovine mesenteric lymphatics. Am J Physiol Heart Circ Physiol.1989; 239: H88–H95.
84. Ohhashi T. Mechanisms for regulating tone in lymphatic vessels. Biochem Pharmacol. 1993; 45: 1941–1946.
85. Ogino K., Burkhoff D., Bilezikian J.P. The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein. Endocrinology. 1995; 136: 3024–3030.
86. Ogino K., Ogura K., Kinugasa Y. et al. Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure. J. ClinEndocrinMetab. 2002; 87: 4722–4727.
87. Okano K., Pirola C.J., Wang H.-M. et al. Involvement of cell cycle and mitogen-activated pathways in induction of parathyroid hormone relayed protein gene expression in rat aortic smooth muscle cells. Endocrinology. 1995; V. 136: 1782–1789.
88. Olszewski W.L., Engeset A. Intrinsic contractility of prenodal lymph vessels and lymph flow in human leg. Am J Physiol Heart Circ Physiol. 1980; 239: H775–H783.
89. Ono N., Mizuno R., Nojiri H., Ohhashi T. Development of an experimental apparatus for investigating lymphatic pumping activity of murine mesentery in vivo. Jpn J Physiol. 2000; 50: 25–31.
90. Orloff J.J., Reddy D., de Papp A.E. et al. Parathyroid hormone-related protein as a prohor-mone: posttranslational processing and receptor interactions. Endocr Rev. 1994; 15: 40–60.
91. Ozeki S., Ohtsuru A., Seto S. et al. Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis. Increased gene expression in the intima of injured carotid arteries and human restenotic coronary lesions. Arterioscler. Thromb. Vasc. Biol. 1996; 16: 565–575.
92. Pagliarulo C., Salvatore P., Napoli C. Targeting vascular niche by parathyroid hormone. Curr Med Chem. 2008; 15: 2984–2990.
93. Philbrick W.M., Wysolmersli J.J., Galbraith S. et al. Defining the roles of the parathyroid hormone-related protein in normal physiology. Physiological Reviews. 1996; 76: 127–173.
94. Pirola C.J., Wang H.M., Kamyar A. et al. Angiotensin II regulates parathyroidhormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and post-transcriptional mechanisms. J. Biol. Chem. 1993; 268: 1987–1994.
95. Pirola C.J., Wang H.M., Strgacich M.I. et al. Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro. Endocrinology. 1994; 134: 2230–2236.
96. Prosser C.G., Farr V.C., Davis S.R. Increased mammary blood flow in the lactating goat induced by parathyroid hormone-related protein. Exp. Physiol. 1994; 79: 565–570.
97. Qian J., Lorenz J.N., Maeda S. et al. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology. 1999; 140: 1826–1833.
98. Quant M. Effects of age on cardiovascular responses to parathyroid hormone and parathyroid hormone-related protein. URL: http://hdl.handle.net/2346/61076.
99. Raj J.U., Chen P. Effect of edema on segmental vascular resistance in isolated lamb lungs determined by micropuncture. CircRes. 1987; 61: 236–243.
100. Rian E., Jemtland R., Olstad O. et al., Parathyroid hormone-related protein is produced by cultured endothelial cells: a possible role in angiogenesis. Biochem. Biophys. Res. Commun. 1994; 198: 740–747.
101. Riddle R.C., Macica C.M., Clemens T.L. Principles of Bone Biology (Third Edition). 2008, V 1 Chapter 34. Vascular, Cardiovascular, and Neurological Actions of Parathyroid-Related Protein. Pages 733–748.
102. Roca-Cusache A., Dipette D.J., Nickols G.A. Regional and systemic hemodynamic effects of parathyroid hormone-related protein: preservation of cardiac function and coronary and renal flowwith reduced blood pressure. J. Pharmacol ExpTher. 1991; 256: 110–118.
103. Ross G., Schluter K.-D. Cardiac-specific effects of parathyroid hormone-related peptide: Modification by aging and hypertension. Cardiovascular Research. 2005; 66: 334–344.
104. Rudolph A.M. Fetal and neonatal pulmonary circulation. Annu Rev Physiol. 1979; 41: 383–395.
105. Sakai H., Ikomi F., Ohhashi T. Effects of endothelin on spontaneous contractions in lymh vessels. Am J Physiol Heart Circ Physiol. 1999; 277: H459–H466.
106. Schluter K., Katzer C., Frischkopf K. et al. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ. Res. 2000; 86: 946–951.
107. Schluter K.-D. PTH and PTHrP: similar structures but different functions. Physiology. 1999; 14 (6): 243-249.
108. Schluter K.-D., Piper H.M. Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide. Cardiovasc. Res. 1998; 37: 34–41.
109. Schluter K.-D., Weber M., Piper H.M. Effects of PTHrP(107–111) and PTHrP(7–34) on adult cardiomyocytes. J. Mol. Cell. Cardiol. 1997; Nov; 29 (11): 3057-65.
110. Schluter K.-D., Weber M., Piper H.M. Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesteras activity. Biochem J. 1995; 310: 439-444.
111. Schluter K.-D., Wingender E., Tegge W., Piper H.M. Parathyroid hormone-related protein antagonizes the action of parathyroid hormone on adult cardiomyocytes. J. Biol. Chem. 1996; 271: 3074–3078.
113. Schreckenberg R., Wenzel S., da Costa Rebelo R.M. et al. Cell-Specific Effects of Nitric Oxide Deficiency on Parathyroid Hormone-Related Peptide (PTHrP) Responsiveness and PTH1 Receptor Expression in Cardiovascular Cells. Endocrinology. 2009; 150 (8): 3735-3741.
114. Schulz R. Parathyroid hormone-related peptide improves contractile function of stunned myocardium in rats and pigs. Am. J. Physiol. 2003; 284: H49–H55.
115. Shan J.1., Pang P.K., Lin H.C., Yang M.C. Cardiovascular effects of human parathyroid hormone and parathyroid hormone-related peptide. J. Cardiovasc. Pharmacol. 1994; 23 Suppl 2: S38-41.
116. Shenberger J.S., Shew R.L., Johnson D.E., Kannan M.S. Relaxation of porcine tracheal smooth muscle by parathyroid hormone-related protein. Respir Physiol. 1997; 107 (1): 59–66.
117. Sicari B.M., Troxell R., Salim F. et al. C-myc and skp2 coordinate p27 degradation, vascular smooth muscle proliferation, and neointima formation induced by the parathyroid hormone-related protein. Endocrinology. 2012; 153: 861–872.
118. Strewler G.J. The physiology of parathyroid hormone-related protein. New Eng. J. Med. 2000; 342: 177–185.
119. Strewler G.J., Stem P.H., Jacobs J.W. et al. Parathyroid hormonelike protein from human renal carcinoma cells structural and functional homology with parathyroid hormone. J. Clin. Invest. 1987; 80: 1803–1807.
120. Stuart W.D., Maeda S., Khera P. et al. Parathyroid hormone-related protein induces G1phase growth arrest of vascular smooth muscle cells. Am J PhysiolEndocrinolMetab. 2000; 279 (1): 60–67.
121. Sutliff R.L., Weber C.S., Qian J. et al. Vasorelaxant properties of parathyroid hormone-related protein in the mouse: Evidence for endothelium involvement independent of nitric oxide formation. Endocrinology. 1999; 140 (5): 2077-2083.
122. Uretsky S., Messerli F.H., Bangalore S. et al. Obesity paradox in patients with hypertension and coronary artery disease. Am. J. Med. 2007; 120: 863-870.
123. Ventura J.L. M., Ortego M., Esbrit P., Miguel Angel Hernandez-Presa, Luis Ortega, Jesus Egido. Possible Role of Parathyroid Hormone–Related Protein as a Proinflammatory Cytokine in Atherosclerosis. Stroke. 2003; 34: 1783-1789.
124. Welsch S., Schordan E., Coquard C., Massfelder T., Fiaschi-Taesch N., Helwig J.J., Barthelmebs M. 2006. Abnormal renovascular parathyroid hormone-1 receptor in hypertension: primary defect or secondary to angiotensin II type 1 receptor activation Endocrinology. 2006; 147: 4384–4391.
125. Wu S., Pirola C., Green J. et al. Effects of N-terminal, midregion, and C-terminal parathyroid hormone-related peptides on adenosine 3,5-monophosphate and cytoplasmic free calcium in rat aortic smooth muscle cells and UMR-106 osteoblast-like cells. Endocrinology. 1993; 133: 2437–2444.
127. Yamamoto M., Harm S.C., Grasser W.A., Thiede M.A. Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. Proc. Natl. Acad. Sci USA. 1992; 89: 5326-5330.
128. Zhang, H., Gao, Y., Wang, Y., et al. The effects of parathyroid hormone-related peptide on cardiac angiogenesis, apoptosis, and function in mice with myocardial infarction. J Cell Biochem. 2019; 120: 14745-14755. https://doi.org/10.1002/jcb.28735